311C90, a new central and peripherally acting 5-HT1D receptor agonist in the acute oral treatment of migraine: a double-blind, placebo-controlled, dose-range finding study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples